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People with fibromyalgia (FM), classified according the American College of Rheumatology 1990 criteria (1), are 
viewed as a homogeneous group. However, both health care 
professionals and researchers often state that FM patients with 
widespread pain for at least six months in combination with 
tenderness at 11 or more of the 18 specific tender points are 
extremely heterogeneous with regard to their biopsychosocial 
impairments and responsiveness to interventions. Classification 
of people with FM into homogeneous subgroups may be an 
important objective to tailor interventions and control for 
orIgInal artIcle
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INTRODUCTION: The present study aimed to replicate and validate 
the empirically derived subgroup classification based on the 
Multidimensional Pain Inventory (MPI) in a sample of highly disabled 
fibromyalgia (FM) patients. Second, it examined how the identified sub-
groups differed in their response to an intensive, interdisciplinary inpatient 
pain management program. 
METHODS: Participants were 118 persons with FM who experienced 
persistent pain and were disabled. Subgroup classification was conducted 
by cluster analysis using MPI subscale scores at entry to the program. At 
program entry and discharge, participants completed the MPI, Medical 
Outcomes Study Short Form-36, Hospital Anxiety and Depression Scale 
and Coping Strategies Questionnaire. 
RESULTS: Cluster analysis identified three subgroups in the highly dis-
abled sample that were similar to those described by other studies using less 
disabled samples of FM. The dysfunctional subgroup (DYS; 36% of the 
sample) showed the highest level of depression, the interpersonally dis-
tressed subgroup (ID; 24%) showed a modest level of depression and the 
adaptive copers subgroup (AC; 38%) showed the lowest depression scores 
in the MPI (negative mood), Medical Outcomes Study Short Form-36 
(mental health), Hospital Anxiety and Depression Scale (depression) and 
Coping Strategies Questionnaire (catastrophizing). Significant differences 
in treatment outcome were observed among the three subgroups in terms 
of reduction of pain severity (as assessed using the MPI). The effect sizes 
were 1.42 for DYS, 1.32 for AC and 0.62 for ID (P=0.004 for pairwise 
comparison of ID-AC and P=0.018 for ID-DYS). 
DISCUSSION: These findings underscore the importance of assessing 
individuals’ differences in how they adjust to FM.
Key Words: Cluster analysis; Fibromyalgia (FM); MPI; Pain management 
program; Subgroups
La classification des personnes ayant une 
fibromyalgie dans des sous-groupes de 
l’inventaire multidimensionnel de la douleur 
permet-elle de déceler des différences d’issues 
après un programme standard de prise en 
charge de la douleur chronique ?
INTRODUCTION : La présente étude visait à répliquer et à valider la 
classification de sous-groupe empirique fondée sur l’inventaire 
multidimensionnel de la douleur (IMD) dans un échantillon de patients 
atteints de fibromyalgie (FM) hautement handicapés. Elle a ensuite permis 
d’examiner les différences de réponse entre les sous-groupes repérés dans le 
cadre d’un programme intensif et interdisciplinaire de prise en charge de la 
douleur chez les patients hospitalisés.
MÉTHODOLOGIE : Les 118 participants étaient atteints de FM, 
souffraient de douleurs persistante et étaient handicapés par leur maladie. 
Les auteurs ont classé les sous-groupes au moyen d’une analyse par grappe 
des indices de sous-groupes de l’IMD au début du programme. Au début du 
programme et au congé, les participants ont rempli l’IMD, le formulaire 
d’étude court sur les issues médicales-36, l’échelle d’anxiété et de dépression 
en milieu hospitalier et le questionnaire de stratégies d’adaptation.
RÉSULTATS : L’analyse par grappe a permis de repérer trois sous-groupes 
de l’échantillon hautement handicapé, similaires à ceux décrits dans 
d’autres études auprès d’échantillons de FM moins handicapés. Le sous-
groupe dysfonctionnel (SDY; 36 % de l’échantillon) a révélé le plus fort 
taux de dépression, le sous-groupe en détresse interpersonnelle (SDI; 
24 %), un taux de dépression modeste et le sous-groupe de personnes 
adaptatives (SPA; 38 %), les indices de dépression les plus faibles selon 
l’IMD (humeur négative), le formulaire d’étude court sur les issues 
médicales-36 (santé mentale), l’échelle d’anxiété et de dépression en 
milieu hospitalier (dépression) et le questionnaire de stratégies d’adaptation 
(catastrophisation). Les auteurs ont observé des différences importantes 
dans l’issue du traitement des trois sous-groupes pour ce qui est de la 
diminution de la gravité de la douleur (évaluée au moyen de l’IMD). 
L’ampleur de l’effet était de 1,42 pour le SDY, de 1,32 pour le SDI et de 0,62 
pour le SPA (P=0,004 pour la comparaison appariée du SDI-SPA et 
P=0,018 pour celle du SDI-SDY). 
EXPOSÉ : Ces observations soulignent l’importance d’évaluer les 
différences personnelles d’adaptation à la FM.
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subgroup differences when evaluating treatment outcome. The 
process of subclassification is a clinical reality, but is often 
undertaken on an individual level and in an unstructured way 
(2). Recent research shows that persons with FM have profiles 
showing difficulties in both the physical, and functional and 
psychosocial realms (3,4). Several research groups identified 
subgroups of people with FM on the basis of fear of pain, readi-
ness to adopt a self-management approach to chronic pain, or 
psychosocial and behavioural responses to pain (5-7). 
The Multidimensional Pain Inventory (MPI), which meas-
ures a number of psychosocial and behavioural variables, has 
been used to identify subgroups of people with chronic muscu-
loskeletal pain in different settings and with different biomed-
ical diagnoses (8,9). Persons with temporomandibular disorders 
(7), whiplash-associated disorders (10) and back pain (6,11-13) 
have been classified into empirically derived subgroups based 
on analyses of the scales of the MPI. In the studies cited above, 
the MPI differentiated between three distinct subgroups 
labelled as adaptive copers (AC), dysfunctional (DYS) and 
interpersonally distressed (ID) (9,14). The ID cluster is mainly 
characterized by lower levels of perceived solicitous and dis-
traction responses from the patients’ partners or spouses and 
higher levels of punishing responses compared with the AC 
and DYS clusters. The AC cluster, compared with the other 
two subgroups, is characterized by less pain severity, less inter-
ference with everyday life due to pain and less affective distress, 
as well as more perception of life control and higher activity 
level. The persons of the DYS cluster report high pain severity, 
high interference and activity distress, low life control and low 
activity level.
Several studies have attempted to identify MPI subgroups in 
persons with FM (7,15,16). These studies have found the same 
three subgroups identified in other populations. At least one 
study has found that subgroup membership is related to the 
outcome of an outpatient multidisciplinary pain management 
program. Although the results of these studies are interesting, 
they were obtained from samples of FM patients who were 
outpatients and much less disabled than those typically seen in 
inpatient pain management programs. 
The aims of the present study were to investigate whether it 
was possible to replicate and describe the three MPI cluster solu-
tion and profiles found in a less disabled American sample of 
outpatients with FM in a more disabled German-speaking sam-
ple of patients with FM treated in an intensive inpatient pain 
management program; validate the three-cluster solution by 
comparing the three clusters with measures of pain, psychosocial 
function, physical and mental health, anxiety and depression, 
and chronic pain coping strategies; and examine the effects of 
cluster membership on the outcome of a standardized four-week 
interdisciplinary inpatient pain management program. 
The first hypothesis was that moderate validity would be 
found between the MPI subgroups and the corresponding sub-
scales of the Medical Outcomes Study Short Form-36 (SF-36) – 
especially worst physical functioning and mental health in the 
DYS subgroup; the Hospital Anxiety and Depression Scale 
(HADS) – especially most anxiety and depression in the DYS 
subgroup; and the Coping Strategies Questionnaire (CSQ) – 
especially most catastrophizing in the DYS subgroup. Second, 
we hypothesized that, with pairwise comparisons between sub-
groups, the most significant differences in effect sizes (ES) after 
the standard pain management program would be seen between 
the AC and DYS subgroups (with highest ES for DYS). 
METHODS
Setting, participants and procedure
The present study was conducted at the rehabilitation clinic 
“RehaClinic” (Bad Zurzach, Switzerland), which is attended by 
disabled patients who have persistent pain and come from all 
German-speaking countries in Europe. The present report is an 
extension of the recently published cohort study (17).
 All subjects included in the study suffered from FM accord-
ing to the American College of Rheumatology criteria (1), had 
pain for at least six months and were disabled by their pain 
enough to warrant admission to an intensive inpatient pain 
management program. Further inclusion criteria included the 
ability to complete self-assessment questionnaires, which espe-
cially requires sufficient German language skills, and psychoin-
tellectual abilities; and written, signed informed consent. The 
patients with FM were participants in the ‘Zurzach 
Interdisciplinary Pain (German: Schmerz) Program’. The pro-
gram is a four-week, in-house, standardized, interdisciplinary 
pain management program. This program has three main com-
ponents: medical care (including adapted drug therapy), exer-
cise therapy and psychotherapy (mainly cognitive and operant 
behavioural therapy) – a total of over 100 h of therapy. The 
program is intensive. Over the course of treatment, patients 
received, on average, six daily sessions of the following treat-
ments: physiotherapy, aerobic endurance training, qigong and 
tai chi exercises, individual psychotherapy including cognitive 
behavioural therapy, participation in a pain coping group, 
relaxation therapy, humour therapy, information and educa-
tion about pathophysiology of pain mechanisms and manage-
ment of chronic disabling pain, nursery care, and regular 
medical consultations including drug therapy. Individual treat-
ment strategies were identified and discussed during the inter-
disciplinary meetings of the pain management team (2 h per 
week for six patients). Detailed information on inclusion and 
exclusion criteria, as well as interdisciplinary treatment goals, 
are published elsewhere (17).
The present study’s protocol was approved by the 
Independent Local Ethic Commission (Health Department in 
Aarau, Switzerland, no. EK AG 2008/026).
Outcome measures
Sociodemographic data and comorbidities: Sociodemographic 
data were collected using a standardized questionnaire from a 
previous study (18). Additional information about physical 
and mental comorbidities and medication were obtained from 
the medical records.
Psychosocial and behavioural aspects of chronic pain: The 
West Haven-Yale MPI assesses pain and its consequences in 
terms of symptoms, disability, activity, behaviour, mood and 
social relationships (8). The German version of the MPI 
(MPI-D) is a self-reported 51-item inventory with 11 subscales: 
‘pain severity’, ‘interference with pain’, ‘life control’, ‘affective 
distress’ (synonymously described as ‘negative mood’), ‘support’, 
‘punishing responses’, ‘solicitous responses’, ‘distracting 
responses’, ‘social and recreational activities’, ‘household chores’ 
and ‘activities away from home’ (19). The last three subscales 
can be summarized into one subscale – ‘general activities’. The 
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range of each subscale is 0 to 6 (seven points). The internal 
consistency coefficient of the MPI-D subscales has been 
reported to range from 0.63 to 0.94, and the test-retest intra-
class correlation coefficients range from 0.46 to 0.93 (20).
For external validation of the cluster solution and calcula-
tion of ES (entry = baseline in pain program – discharge after 
four weeks), the instruments listed below were used.
Health-related quality of life: The SF-36 is a self-administered 
generic instrument that assesses health-related quality of life 
(21). It consists of four physical scales (‘physical functioning’, 
‘role physical’, ‘bodily pain’ and ‘general health’) and four men-
tal scales (‘vitality’, ‘social functioning’, ‘role emotional’ and 
‘mental health’). The SF-36 has been implemented in numer-
ous studies in over 40 languages worldwide and its clinimetric 
quality has been proven in various settings. The reliability of 
SF-36 scale scores, estimated using internal consistency meth-
ods for 3455 patients, vary with a range of coefficients from 
0.65 to 0.94. Test-retest reliability scale scores, measured over a 
two-week interval, vary from 0.60 to 0.81 (22). The validated 
German version of the SF-36 was used to enquire about symp-
toms and functioning during the preceding four weeks (23). 
Anxiety and depression: The HADS is a short, self-rating meas-
ure of anxiety and depression (seven items each), these being 
two of the most important affective health dimensions for people 
with chronic musculoskeletal pain (24). The questionnaire was 
developed for the evaluation of persons in a nonpsychiatric set-
ting, has a long history of application in chronic pain manage-
ment and has been well tested in large populations and patient 
surveys (25). The validated German version (HADS-D) was 
used. The internal consistency coefficients of the HADS-D sub-
scales are 0.80 (fear subscale) and 0.81 (depression subscale). 
The split-half coefficient is 0.81 for both scales (26).
Coping: The CSQ is an internationally used self-report instru-
ment for assessing active and passive coping strategies; it is used 
by individuals with chronic pain (27,28). This widely used 
measure is a 48-item questionnaire that assesses six cognitive 
(‘diverting attention’, ‘reinterpreting pain sensations’, ‘coping 
self-statements’, ‘ignoring pain sensations’, ‘praying or hoping’, 
and ‘catastrophizing’) and two behavioural (‘increasing activity 
level’ and ‘increasing pain behaviours’) coping strategies. Each 
domain comprises six items, and participants rate the frequency 
of their use of specific coping strategies on a seven-point Likert 
scale from 0 (ie, ‘never do that’) to six (ie, ‘always do that’). 
The CSQ also includes two one-item scales that assess partici-
pants’ subjective ability to control or decrease their pain. 
These two scales measure the perceived effectiveness of partici-
pants’ coping strategies. Using a similar seven-point Likert 
scale, participants rate their ability from 0 to 6, with 0 signi-
fying ‘no control/no ability to decrease pain’ and six signifying 
‘complete control/complete ability to decrease pain’. The 
validated German version of the CSQ (CSQ-D) was used, 
which is a translation and cross-cultural adaptation of the ori-
ginal questionnaire. The internal consistency coefficient of the 
CSQ-D subscales has been reported to range from 0.71 to 0.97, 
and the test-retest intraclass correlation coefficient ranges from 
0.55 to 0.93 (29).
Data analyses
The outcome measures were administered on entry to the 
clinic (baseline, pretreatment) and at discharge from the 
rehabilitation clinic after four weeks (post-treatment). Other 
than as an outcome measure, the baseline scores of the scales of 
the MPI were used for subgroup classification.
The scores of the SF-36, HADS, CSQ, MPI ‘life control, 
MPI ‘support’, MPI ‘solicitous responses’, MPI ‘distracting 
responses’ and MPI ‘general activities’ were scaled from 0 (max-
imal pain/maximal disability/maximal symptoms/worst coping) 
to 100 (no pain/full function/no symptoms/best coping) based 
on a procedure originally described in the SF-36 manual. This 
scaling was performed to ease comparison of the clusters on 
these external validation measures. According to the subgroup 
classification of Turk and Rudy (9), the MPI ‘pain severity’, MPI 
‘interference with pain, MPI ‘affective distress’ and MPI ‘pun-
ishing responses’ were scaled from 0 (best) to 100 (worst). 
Descriptive statistics were determined according to the ‘missing 
rules’ of the instruments’ scores; ie, at least 50% valid items per 
scale for the SF-36, two of three valid items for the MPI and the 
CSQ, and at least six of seven valid items for the HADS. 
According to Turk and Rudy (9), the empirically derived 
subgroups were defined by confirmatory cluster analysis using a 
predefined three-cluster solution. Cluster analysis is an explora-
tory method by which multiple sources of information are 
analyzed simultaneously to group individuals into clusters. 
Individuals within a cluster are similar to each other on the 
variables included in the statistical analysis and differ signifi-
cantly from those in the other cluster groups. The MPI score 
patterns were depicted as graphs of the mean MPI baseline 
scores and compared with the patterns described by Turk et al 
using the rank orders of the three subgroups within one MPI 
scale. To assess whether a three-cluster solution was appropri-
ate according to mathematical criteria, hierarchical cluster 
analysis according to the Ward method was performed (30). 
The resulting diagram with the number of clusters and the 
course of the sum of residual squares did not favour a three-
cluster solution (data not shown in detail). However, factor 
analysis revealed that a factor solution fitted best with three 
factors explaining 67.4% of the variance. Thus, the proposed 
‘best feasible’ (ie, clinically characterized) empirically deter-
mined solution according to the subgroups defined by Turk et 
al was chosen.
To test validity, the SF-36, HADS and CSQ scores had to 
show the same or similar patterns (across the three subgroups) 
within the subscores with a similar construct; eg, the pattern of 
the MPI ‘pain severity’ was compared with the SF-36 ‘bodily 
pain’, and the MPI ‘negative mood’ was compared with SF-36 
‘mental health’, HADS ‘depression’ and CSQ ‘catastrophizing’ 
(31). Pairwise analyses between the three MPI subgroups were 
tested using the Mann-Whitney U test for significance (type 
one error 0.05). 
ES were determined by the score difference between entry 
(baseline) and discharge, divided by the group SD at entry for 
the whole sample and the three subgroups (32). Positive ES 
indicate improvement of the pain condition, while negative ES 
indicate worsening after completion of the pain management 
program. ES of 0.80 or greater are considered to be large, 0.50 
to 0.79 to be moderate, 0.20 to 0.49 to be small and 0.00 to 
0.19 to be very small (32). Pairwise analyses between the three 
MPI subgroups were tested using the Mann-Whitney U test for 
significance (type one error 0.05). The minimal clinically 
important difference (MCID), which is principally a method to 
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assess the smallest effect that patients perceive to be beneficial, 
was added to get an impression of the clinical relevance of the 
effects at discharge (33). If the MCID is less than the lower 
limit of the 95% CI, results are likely to be statistically signifi-
cant and clinically important (34). If the MCID is greater than 
the upper limit of the 95% CI, results are likely to be clinically 
unimportant. If the MCID lies within the limits of the 95% CI, 
it is unclear whether the effect is clinically important.
All analyses were performed using the statistical software 
package SPSS 16.0 for Windows (SPSS Inc, USA).
RESULTS
Participants at baseline
Table 1 describes the demographic and medical data of the 
total sample of patients with FM on entry into the pain man-
agement program (n=118). The present sample is an extension 
of the recently published cohort study of 65 persons with FM 
(17). The subjects were characterized by a relatively young age, 
a long history of pain, high levels of pain, high physical dis-
ability, high prevalence and high levels of depression and anx-
iety, and low psychosocial functioning, as characterized by far 
lower scores than expected by general population norms for 
SF-36 and HADS (17).
Classification of persons with FM by the MPI into 
subgroups
Table 2 and Figure 1 show the mean baseline scores of the MPI. 
A total of 116 of 118 patients with FM could be allocated to 
one of the three chronic pain subgroups obtained by cluster 
analysis of all MPI scales, according to the concept of Turk et 
al (7,9). Twenty-four per cent (n=28) were classified as ID, 
38% (n=45) were classified as AC and 36% (n=43) were clas-
sified as DYS. The two remaining persons with FM were classi-
fied as ‘anomalous’ (did not fit into any of the three profiles). 
With the exception of pain duration – persons with FM in the 
DYS cluster had shorter pain duration than people in the AC 
and ID clusters – no significant differences in demographic and 
medical baseline data were found between the three clusters 
(data not shown in detail). 
Validation of the subgroup classification
Table 3 shows the mean baseline scores and SDs of the scales of 
the SF-36, HADS, and CSQ for the three MPI cluster groups. 
Comparing the results of Table 2 and Table 3, the scores of the 
subgroups of the SF-36, HADS and CSQ showed almost the 
same pattern as the MPI. On the MPI ‘pain severity’, the rank 
order of the three cluster subgroups in terms of reported pain 
was DYS (most pain), AC and ID (least pain). This same order 
was found on the SF-36 ‘bodily pain’; DYS showed most pain 
(bodily pain 10.7; P=0.005 comparing ID with DYS; P=0.014 
comparing AC with DYS). The MPI ‘general activities’ was 
compared with SF-36 ‘physical functioning’; DYS showed the 
lowest activity level (‘physical functioning’ 26.1; P=0.001 
comparing ID with DYS and AC with DYS). The same was 
consistently true when comparing MPI ‘interference with pain’ 
with SF-36 ‘physical functioning’. The mean baseline score of 
MPI ‘life control’ was compared with the score of CSQ ‘ability 
to control pain’; AC had best control (48.2; P=0.016 compar-
ing ID with AC). The MPI ‘affective distress’ was compared 
with the SF-36 ‘mental health’, HADS ‘depression’ and ‘anx-
iety’, and CSQ ‘catastrophizing’; DYS showed the most and 
AC showed the least affective symptoms in all scales (signifi-
cant differences in various pairwise subgroup comparisons). It 
was not possible to replicate the specific MPI characteristics of 
the ID subgroup (punishing responses and lack of support by 
partner or spouse) because the scores of the subscales of the 
SF-36, HADS and CSQ are not able to measure social support. 
Overall, the differences of scores between the three clusters 
were in agreement with theoretical expectations and implied 
support for moderate validity.
Differential treatment responses within the MPI subgroups
Table 4 shows significant differences between the scores of the 
ES of pairwise comparisons between the three MPI subgroups 
that were found for four MPI scales (pain severity, interference 
with pain, affective distress and support), two SF-36 scales 
(physical functioning and social functioning) and three CSQ 
scales (increasing activity level, ability to control pain and 
ability to decrease pain). For example, significant differences in 
treatment outcome were observed among the three subgroups 
in terms of pain severity, as assessed using the MPI. The ES 
were 1.42 for DYS, 1.32 for AC and 0.62 for ID (P=0.004 for 
pairwise comparison of ID-AC and P=0.018 for ID-DYS). 
Also, significant differences in treatment outcome could be 
Table 1
Demographic and medical data for the total sample of 
persons with fibromyalgia at entry to the pain program 
(n=118)
Age, mean ± SD (range), years 45.5±9.8 (19.7–67.2)
Female sex 95.8
Marital status
Single 16.7
Married 68.4
Other 14.9
Education
Grade 10–12 31.6
High school graduate 50.0
College graduate 12.3
University graduate 6.1
Employment status
Full time 12.3
Part time 43.0
Unemployed 42.1
Retired 2.6
Use of medication
No medication 3.4
NSAR medication or acetaminophen 49.3
Opioids or opiates 17.0
Antidepressants 20.4
Depression
No depression 28.0
Depression 72.0
Pain duration
7–12 months 3.5
13–24 months 9.6
25–36 months 7.0
37–48 months 7.0
49–60 months 27.8
>5 years 44.1
Data presented as percentages unless otherwise indicated. NSAR Nonsteroidal 
antirheumatic
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measured in terms of physical functioning, as assessed using the 
SF-36. The ES were 0.82 for DYS, 0.69 for AC and 0.22 for ID 
(P=0.028 for pairwise comparison of ID-AC and P=0.090 for 
ID-DYS). 
Comparing the three MPI subgroups, the DYS cluster 
showed the highest effects in MPI pain severity (ES=1.42) and 
interference with pain (ES=1.55), and SF-36 physical func-
tioning (ES=0.82), but also the least improvement in SF-36 
social functioning (ES=0.40), worsening in CSQ increasing 
activity level (ES=–0.17), and the least improvement in CSQ 
ability to control pain (ES=0.19) and ability to decrease pain 
(ES=0.41). The AC cluster showed most improvement in MPI 
support (ES=0.39) and CSQ increasing activity level 
(ES=0.27).
DISCUSSION
Summary of main findings
The findings of the present study showed that the MPI sub-
groups previously identified in less disabled samples of FM 
patients are also evident in a highly disabled FM sample. The 
three subgroups identified (DYS, ID and AC) showed signifi-
cant differences in pain severity outcomes following a standard 
inpatient pain management program. The results of the present 
study suggest that, by attending to FM patients’ subgroup 
status, one may be able to individualize some of the patient 
management efforts.
Comparison with other studies
Our results after completing the four-week pain management 
program challenge the conclusions of the study of Turk et al 
(15). An analysis of 48 American patients with FM, who com-
pleted a six-half day outpatient pain management program 
consisting of medical, physical, occupational and psychological 
therapies spaced over a period of four weeks, revealed that per-
sons in the DYS subgroup seemed to benefit most from the pain 
program (11). After completing this less intensive pain pro-
gram, these persons showed significant improvement in pain 
severity, self-reported disability and psychological distress. In 
contrast, the persons in the AC subgroup showed significant 
improvement in pain severity but their self-reported psycho-
logical distress and disability did not change (Table 5). 
Therefore, Turk et al (15) raised the question of whether these 
persons with FM actually require all the components of the 
outpatient pain management program. In another study by 
King et al (35,36), the subjects were randomly assigned into 
one of three interventions (exercise only, education only, or a 
combination of exercise and education, one to three times per 
week) or a control group. This study (n=128) stated that no 
MPI subgroup responded more than another subgroup on any of 
the instruments involved. With the exceptions of pain severity 
and depression in the DYS subgroup, our patients showed larger 
ES in all subgroups when compared with the study of Turk et al 
mentioned previously (15) (Table 5). Especially in the ID sub-
group (physical functioning) and the AC subgroup (physical 
functioning and depression), in which Turk et al found no effect 
(ES=–0.03 to 0.01), our patients showed at least small (ES=0.22) 
to moderate (ES=0.50 and 0.69) ES. One explanation may be 
the different interventions and differences in treatment inten-
sity. Our standard four-week inpatient pain management pro-
gram involved a broad array of chronic pain management 
strategies (active individual physiotherapy, aerobic endurance 
training, individual psychology, participation in a pain coping 
group, relaxation therapy, humour therapy, occupational ther-
apy, qigong and tai chi, information about neurophysiology of 
pain and the possible contribution of psychosocial aspects in 
chronic pain, nursery care, and medical consultations including 
drug therapy) and was more intense; therapies were adminis-
tered up to 6 h per day and six days per week (17). Another 
explanation may be that, although the patients in the AC sub-
group at entry to the pain program scored better than the other 
two subgroups, their burden of disease was nevertheless substan-
tial compared with available normative data collected from 
healthier outpatient samples.
Table 2
Mean Multidimensional Pain Inventory (MPI) subscale baseline scores and pairwise analyses for significance of the three 
cluster groups
MPI subscales ID (n=28) aC (n=45) DYS (n=43) ID-aC ID-DYS aC-DYS
Pain severity (6 = worst, most) 4.25±1.01 4.58±0.80 5.30±0.62 0.090 <0.001* <0.001*
Interference with pain (6 = worst, most) 4.04±16.8 4.17±0.85 5.08±0.51 ns <0.001* <0.001*
Life control (6 = best, most) 2.51±1.09 3.27±1.16 2.25±1.13 0.010* 0.193 <0.001*
Affective distress (6 = worst, most) 3.63±1.17 2.91±1.02 4.50±0.82 0.011*   0.001* <0.001*
Support (6 = best, most) 1.58±1.16 4.66±1.09 5.15±0.99 <0.001* <0.001* 0.026*
Punishing responses (6 = worst, most) 1.73±1.84 0.80±0.94 2.01±1.49 0.086 ns <0.001*
Solicitous responses (6 = best, most) 1.14±1.03 3.69±1.15 4.34±1.10 <0.001* <0.001*   0.018*
Distracting responses (6 = best, most) 1.08±1.21 3.62±1.38 3.89±1.19 <0.001* <0.001* ns
General activities (6 = best, most) 2.42±0.86 2.66±0.73 2.11±0.75 ns ns   0.001*
Data presented as mean ± SD unless otherwise indicated. *Significance level P≤0.050. AC MPI cluster adaptive copers; DYS MPI cluster dysfunctional; ID MPI 
cluster interpersonally distressed; ns Not significant (P>0.050)
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Figure 1) Mean baseline scores for patient profiles on the German 
version of the Multidimensional Pain Inventory
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Validation of the subgroup pattern
In support of the first hypothesis, the score differences at entry 
between the subgroups, as described by the MPI, were consist-
ent with comparable constructs measured using the SF-36, 
HADS and CSQ. The persons in the AC cluster showed better 
general and mental health, less fear and depression, less catas-
trophizing and better self-efficacy (ability to control and 
decrease their pain) than persons in the DYS cluster. The per-
sons in the DYS cluster reported higher levels of pain, anxiety, 
depression and use of maladaptive coping strategies (praying 
and hoping, and catastrophizing), and the lowest levels of 
physical function, social function and mental health compared 
with the AC cluster (Table 3). The ID pattern of the MPI 
could not be replicated by the other instruments due to the 
lack of scales with comparable construct.
Differences in effect between MPI subgroups 
Our second hypothesis was that, with pairwise comparisons 
between subgroups at discharge, we expected to find the high-
est ES for DYS and most significant differences in effects 
between the AC and DYS subgroups. This hypothesis can be 
partly confirmed by our results – the hypothesis was true for 
pain (MPI and SF-36), interference with pain (MPI), activities 
and function (MPI and SF-36), and affective health (MPI, 
SF-36, HADS and CSQ catastrophizing). However, some of 
these effect differences were small and did not reach signifi-
cance. No other scales showed significant differences.
Clinical implications for pain management program 
The present study showed, for most scales, positive small (ES = 
0.20 to 0.49) to large (ES>0.80) ES for the total population of 
116 persons with FM, as well as for the corresponding clusters. 
Nevertheless, there were significant differences in outcome 
between MPI subgroups in 17 of 87 pairwise comparisons (last 
three columns of Table 4). This retrospective MPI subgroup 
classification (a posteriori) provides information that may help 
to improve the effects of standard pain management programs. 
It suggests matching persons with the treatment strategies and 
therapeutic methods they are most likely to respond to and 
where they show the greatest need of treatment and/or where 
they show the largest deficits (17). The development and 
implementation (a priori) of classification methods for match-
ing interventions of pain management programs to subgroups 
of patients may improve clinical outcomes. Several recent 
studies in the field of (sub-) acute ‘nonspecific’ low back pain 
and acute neck pain have provided preliminary evidence that 
using specific inclusion criteria to identify more homogeneous 
subgroups of subjects, and attempting to match treatment to 
the subgroup, has the potential to enhance treatment effects 
(37-42).
Future research directions 
A focus of research may be the further analysis of the AC 
subgroup. Although these people score better than the other 
two subgroups with self-report measures on pain, self- 
perceived disability, mental health and their ability to cope 
with chronic pain, the impact of musculoskeletal pain on 
their consumption of pain medication and therapeutic inter-
ventions, physical performance, not returning to work, etc, is 
comparable with the ID and DYS subgroups. Aspects of over-
use behaviour have been hypothesized and are subject of fur-
ther research (43-48).
Limitations of the present study
The sample consisted of selected persons who had suffered from 
severe and disabling chronic pain disorders for a long time and 
who fulfilled certain criteria (eg, motivation and ability to 
understand German). Therefore, they may differ in important 
Table 3
Mean baseline scores and pairwise analyses for significance of the scales of the Medical Outcomes Studies Short Form-36 
(SF-36), the Hospital anxiety and Depression Scale (HaDS) and the Coping Strategies Questionnaire (CSQ) for the three 
Multidimensional Pain Inventory (MPI) cluster groups
Subscales ID (n=28) aC (n=45) DYS (n=43) ID-aC ID-DYS aC-DYS
SF-36 (100 = best)
Physical functioning 43.6±22.2 40.1±13.4 26.1±15.8 ns 0.001* 0.001*
Bodily pain 19.9±14.0 18.0±14.5 10.7±10.7 ns 0.005*   0.014*
General health 37.3±13.0 42.2±14.3 34.5±12.1 ns ns   0.015*
Vitality 19.8±16.4 26.7±15.6 16.1±14.3 0.092 ns <0.001*
Social functioning 36.4±19.9 44.4±24.1 35.7±26.1 ns ns 0.086
Role emotional 17.8±26.4 38.5±43.8 16.3±32.0 0.083 ns   0.009*
Mental health 42.3±17.5 52.1±16.3 32.3±15.2 0.074 0.006* <0.001*
HADS (100 = no anxiety or depression)
Anxiety 47.6±20.2 55.0±20.1 37.9±18.6 ns 0.053 <0.001*
Depression 51.4±20.5 63.5±17.1 45.9±18.4 0.009* ns <0.001*
CSQ (100 = best)
Diverting attention 42.4±18.0 54.4±18.7 54.5±16.7 0.007* 0.005* ns
Praying or hoping 58.8±22.9 50.7±25.2 41.5±21.6 ns 0.002* ns
Catastrophizing 44.6±15.5 52.2±19.1 33.9±16.3 ns 0.003* <0.001*
Increasing activity level 52.5±15.3 58.4±15.4 58.0±15.8 0.090 ns ns
Pain behaviours 56.6±12.4 60.2±14.1 66.0±13.3 ns 0.007* 0.070
Ability to control pain 34.5±23.1 48.2±22.5 41.7±23.4 0.016* ns ns
Ability to decrease pain 25.6±17.9 45.2±20.6 36.5±19.9 0.001* 0.030* 0.051
Data provided as mean ± SD. *Significance level P≤0.050. AC MPI cluster adaptive copers; DYS MPI cluster dysfunctional; ID MPI cluster interpersonally distressed; 
ns Not significant (P>0.050)
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ways from people with FM in general, thus limiting the gener-
alizability of the results. Because the design of the study did not 
include a control group, the changes after the pain program can 
not be solely attributed to the interventions. The number of 
persons in each subgroup was relatively small (n=28, n=45 and 
n=43 for the ID, AC and DYS clusters, respectively), but larger 
than a comparable study (11). Another limitation is the short-
term measurement of effects (between entry and discharge 
from the rehabilitation clinic after four weeks). Future studies 
should use standardized outcome measurements, not only at 
the end of the experimental program, but at follow-up times 
that are long enough for the person with FM to modify 
Table 4
Cluster differences in effects and pairwise analyses for significance after the four-week pain management program (entry to 
discharge)
Subscales eS-all (95% CI) eS-ID (95% CI) eS-aC (95% CI) eS-DYS (95% CI) MCID (eS) ID-aC ID-DYS aC-DYS
MPI
Pain severity 0.98 (0.79–1.17) 0.62 (0.25–1.00) 1.32 (1.00–1.64) 1.42 (0.96–1.87) 0.42 0.004* 0.018* ns
Interference with pain 0.76 (0.60–0.92) 0.47 (0.21–0.73) 0.87 (0.58–1.16) 1.55 (1.05–2.06) 0.37 ns 0.001* 0.039*
Life control 0.53 (0.32–0.73) 0.56 (0.15–0.97) 0.55 (0.19–0.91) 0.58 (0.18–0.97) 0.53 ns ns ns
Affective distress 0.79 (0.61–0.96) 0.71 (0.35–1.07) 0.75 (0.49–1.02) 1.36 (0.85–1.88) 0.56 ns 0.072 0.086
Support 0.09 (–0.02–0.21) –0.26 (–0.67–0.16) 0.39 (0.11–0.67) 0.20 (–0.06–0.46) 0.45 0.013* 0.050* ns
Punishing responses 0.07 (–0.11–0.26) 0.23 (–0.06–0.52) –0.08 (–0.38–0.23) 0.14 (–0.26–0.54) 0.40 ns ns ns
Solicitous responses –0.03 (–0.14–0.08) 0.24 (–0.10–0.59) –0.01 (–0.29–0.28) –0.27 (–0.57–0.03) 0.33 ns ns ns
Distracting responses 0.03 (–0.09–0.16) 0.41 (0.04–0.79) –0.08 (–0.38–0.23) –0.05 (–0.30–0.21) 0.62 ns ns ns
General activities 0.16 (0.03–0.28) 0.08 (–0.11–0.28) 0.07 (–0.16–0.30) 0.30 (0.08–0.53) 0.37 ns ns ns
SF-36
Physical functioning 0.56 (0.39–0.72) 0.22 (–0.11–0.56) 0.69 (0.47–0.90) 0.82 (0.42–1.22) 0.26 0.028* 0.090 ns
Role physical 0.81 (0.46–1.16) 0.52 (–0.05–1.00) 0.87 (0.32–1.43) 0.91 (0.22–1.60) 0.30 ns ns ns
Bodily pain 0.83 (0.64–1.03) 0.88 (0.46–1.31) 0.73 (0.44–1.02) 1.06 (0.65–1.47) 0.33 ns ns ns
General health 0.41 (0.22–0.60) 0.54 (0.17–0.91) 0.41 (0.10–0.72) 0.33 (–0.05–0.70) 0.57 ns ns ns
Vitality 1.03 (0.83–1.23) 1.02 (0.61–1.42) 1.09 (0.76–1.42) 1.12 (0.74–1.50) 0.37 ns ns ns
Social functioning 0.62 (0.44–0.81) 0.84 (0.35–1.32) 0.77 (0.48–1.06) 0.40 (0.10–0.70) 0.41 ns 0.063 0.010*
Role emotional 0.40 (0.17–0.63) 1.09 (0.40–1.77) 0.35 (–0.01–0.71) 0.30 (–0.07–0.66) 0.32 ns ns ns
Mental health 0.62 (0.47–0.78) 0.60 (0.20–1.00) 0.60 (0.36–0.84) 0.93 (0.64–1.23) 0.39 ns ns ns
HADS
Anxiety 0.41 (0.26–0.56) 0.26 (–0.07–0.59) 0.47 (0.25–0.69) 0.52 (0.22–0.81) 0.44 ns ns ns
Depression 0.47 (0.34–0.61) 0.50 (0.17–0.82) 0.50 (0.28–0.71) 0.54 (0.30–0.79) 0.33 ns ns ns
CSQ
Diverting attention 0.09 (–0.05–0.22) 0.04 (–0.17–0.25) 0.07 (–0.17–0.32) 0.12 (–0.13–0.36) 0.35 ns ns ns
Reinterpreting pain 0.15 (0.01–0.30) –0.06 (–0.35–0.23) 0.30 (0.05–0.56) 0.12 (–0.07–0.32) 0.32 ns ns ns
Self-statements –0.05 (–0.20–0.10) –0.07 (–0.42–0.27) –0.12 (–0.37–0.13) 0.09 (–0.11–0.30) 0.36 ns ns ns
Ignoring pain –0.02 (–0.17–0.13) 0.02 (–0.30–0.35) 0.05 (–0.22–0.33) –0.03 (–0.21–0.15) 0.26 ns ns ns
Praying or hoping 0.20 (0.11–0.29) 0.22 (0.05–0.39) 0.20 (0.06–0.34) 0.21 (0.02–0.40) 0.28 ns ns ns
Catastrophizing 0.47 (0.34–0.61) 0.41 (0.10–0.72) 0.49 (0.27–0.70) 0.57 (0.30–0.84) 0.26 ns ns ns
Increasing activity level 0.11 (–0.03–0.25) 0.24 (–0.03–0.51) 0.27 (0.03–0.52) –0.17 (–0.38–0.04) 0.30 ns 0.046* 0.030*
Pain behaviours –0.13 (–0.25–0.00) –0.14 (–0.45–0.16) –0.09 (–0.25–0.07) –0.18 (–0.43–0.07) 0.39 ns ns ns
Ability to control pain 0.38 (0.20–0.57) 0.62 (0.22–1.02) 0.41 (0.11–0.71) 0.19 (–0.13–0.51) 0.42 ns 0.021* ns
Ability to decrease pain 0.55 (0.36–0.74) 1.10 (0.66–1.54) 0.42 (0.10–0.74) 0.41 (0.08–0.73) 0.67 0.003* 0.002* ns
*Significance level P≤0.050. AC MPI cluster adaptive copers, n=45; CSQ Coping Strategies Questionnaire; DYS MPI cluster dysfunctional, n=43; ES Effect size; 
ES-All ES of all 116 fibromyalgia patients (not divided into clusters); HADS Hospital Anxiety and Depression Scale; ID MPI cluster interpersonally distressed, n=28; 
MCID Minimal clinically important difference, in ES units; MPI Multidimensional Pain Inventory; ns Not significant (P>0.050); SF-36 Medical Outcomes Studies Short 
Form-36 
Table 5
Comparison of differences in effect sizes (eS) from entry to discharge between the american four-week outpatient pain 
management program (Turk et al [15]; six half-days) and the present Swiss four-week inpatient pain management program 
(Verra et al; 29 days, up to 6 h of therapy per day)
Dysfunctional eS Interpersonally distressed eS adaptive copers eS
Turk et al (n=16) Verra et al (n=43) Turk et al (n=17) Verra et al (n=28) Turk et al (n=15) Verra et al (n=45)
MPI pain severity 1.85 1.42 0.21 0.62 1.00 1.32
MPI interference with pain 1.00 1.55 0.20 0.47 0.54 0.87
Physical functioning 0.63 (ODI) 0.82 (SF-36) 0.01 (ODI) 0.22 (SF-36) 0.01 (ODI) 0.69 (SF-36)
Depression 0.80 (CES-D) 0.54 (HADS) 0.44 (CES-D) 0.50 (HADS) –0.03 (CES-D) 0.50 (HADS)
CES-D Center for Epidemiological Studies Depression Scale; HADS Hospital Anxiety and Depression Scale, depression subscale; MPI Multidimensional Pain 
Inventory; ODI Oswestry Disability Inventory; SF-36 Medical Outcomes Studies Short Form-36, physical functioning subscale. Data from reference 15 and the pres-
ent study
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behaviour patterns and master effective strategies (49). When 
using a post- or pretest difference to define improvement after 
an intervention, the possibility of regression toward the mean 
cannot be excluded. We aimed to minimize this effect by using 
only reliable measurement instruments that have been used 
previously with persons with FM (35). Also, all outcome vari-
ables were obtained from self-reported questionnaires; eg, MPI 
general activities screening for perceived disability and not 
observing physical performance. Finally, one study was able to 
demonstrate that, in two samples of persons with FM, MPI 
classifications may not be stable, trait-like characterizations. 
As such, caution must be applied when treatment is tailored to 
MPI clusters (50). However, new evidence from the data of 976 
pain patients provides evidence for the stability and replicabil-
ity of three new clusters based on the MPI system (51).
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